Exposure to gonadotropins for subfertility vs general population and endometrial cancer risk: Endometrial cancer
It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Exposure to gonadotropins for subfertility vs general population and endometrial cancer risk Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty). Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility (2017) · Cochrane Headline outcomes only | RR 2.12 [0.79, 5.64] | 2 studies · 1595 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.